Transcend Capital Advisors’s Aptose Biosciences, Inc. APTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-53
| Closed | -$15.4K | – | 517 |
|
|
2023
Q1 | $15.4K | Hold |
53
| – | – | ﹤0.01% | 476 |
|
|
2022
Q4 | $13.9K | Hold |
53
| – | – | ﹤0.01% | 487 |
|
|
2022
Q3 | $14K | Hold |
53
| – | – | ﹤0.01% | 477 |
|
|
2022
Q2 | $18K | Hold |
53
| – | – | ﹤0.01% | 492 |
|
|
2022
Q1 | $33K | Hold |
53
| – | – | ﹤0.01% | 508 |
|
|
2021
Q4 | $32K | Hold |
53
| – | – | ﹤0.01% | 481 |
|
|
2021
Q3 | $50K | Hold |
53
| – | – | ﹤0.01% | 483 |
|
|
2021
Q2 | $80K | Hold |
53
| – | – | 0.01% | 320 |
|
|
2021
Q1 | $144K | Buy |
+53
| New | +$144K | 0.02% | 399 |
|